A multicentre, interventional, parallel group, randomised, open-label, exploratory study to assess the earlier introduction of Ivabradine in the Management of Systolic Dysfunction Heart Failure. The QUALIVA study

Trial Profile

A multicentre, interventional, parallel group, randomised, open-label, exploratory study to assess the earlier introduction of Ivabradine in the Management of Systolic Dysfunction Heart Failure. The QUALIVA study

Completed
Phase of Trial: Phase II

Latest Information Update: 30 Jun 2016

At a glance

  • Drugs Ivabradine (Primary) ; Bisoprolol; Carvedilol
  • Indications Heart failure
  • Focus Therapeutic Use
  • Acronyms QUALIVA
  • Most Recent Events

    • 30 Jun 2016 Status changed from recruiting to completed.
    • 09 Oct 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top